drug · small molecule
plixorafenib
Phase 2updated 3mo agoby Fore Biotherapeutics Inc🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 9 investigational indications.
indications
indications
Glioblastoma
targets
Serine/threonine-protein kinase B-raf
all catalysts(0)
nothing on the calendar yet
Trials studying plixorafenib
- phase2A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- EP1A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma
- phase1A Study of the Effects of Food and Cobicistat on Plixorafenib Pharmacokinetics in Healthy Participants.
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 50m ago
Found something off?
comments(0)
5-min edit window · permanent after that